Global Nanotechnology Drug Delivery Systems Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Nanocrystals
1.2.3 Nanoparticles
1.2.4 Dendrimers
1.2.5 Gold Nanoparticles
1.2.6 Fullerenes
1.2.7 Liposomes
1.2.8 Nanotubes
1.2.9 Others
1.3 Market by Application
1.3.1 Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunology
1.3.3 Cardiovascular
1.3.4 Neurology
1.3.5 Oncology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology Drug Delivery Systems Market Perspective (2018-2029)
2.2 Global Nanotechnology Drug Delivery Systems Growth Trends by Region
2.2.1 Nanotechnology Drug Delivery Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nanotechnology Drug Delivery Systems Historic Market Size by Region (2018-2023)
2.2.3 Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2024-2029)
2.3 Nanotechnology Drug Delivery Systems Market Dynamics
2.3.1 Nanotechnology Drug Delivery Systems Industry Trends
2.3.2 Nanotechnology Drug Delivery Systems Market Drivers
2.3.3 Nanotechnology Drug Delivery Systems Market Challenges
2.3.4 Nanotechnology Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nanotechnology Drug Delivery Systems by Players
3.1.1 Global Nanotechnology Drug Delivery Systems Revenue by Players (2018-2023)
3.1.2 Global Nanotechnology Drug Delivery Systems Revenue Market Share by Players (2018-2023)
3.2 Global Nanotechnology Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nanotechnology Drug Delivery Systems, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology Drug Delivery Systems Revenue in 2022
3.5 Global Key Players of Nanotechnology Drug Delivery Systems Head office and Area Served
3.6 Global Key Players of Nanotechnology Drug Delivery Systems, Product and Application
3.7 Global Key Players of Nanotechnology Drug Delivery Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology Drug Delivery Systems Breakdown Data by Type
4.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Type (2018-2023)
4.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
5 Nanotechnology Drug Delivery Systems Breakdown Data by Application
5.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Application (2018-2023)
5.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nanotechnology Drug Delivery Systems Market Size (2018-2029)
6.2 North America Nanotechnology Drug Delivery Systems Market Size by Type
6.2.1 North America Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023)
6.2.2 North America Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029)
6.2.3 North America Nanotechnology Drug Delivery Systems Market Share by Type (2018-2029)
6.3 North America Nanotechnology Drug Delivery Systems Market Size by Application
6.3.1 North America Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023)
6.3.2 North America Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029)
6.3.3 North America Nanotechnology Drug Delivery Systems Market Share by Application (2018-2029)
6.4 North America Nanotechnology Drug Delivery Systems Market Size by Country
6.4.1 North America Nanotechnology Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Nanotechnology Drug Delivery Systems Market Size by Country (2018-2023)
6.4.3 North America Nanotechnology Drug Delivery Systems Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nanotechnology Drug Delivery Systems Market Size (2018-2029)
7.2 Europe Nanotechnology Drug Delivery Systems Market Size by Type
7.2.1 Europe Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023)
7.2.2 Europe Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029)
7.2.3 Europe Nanotechnology Drug Delivery Systems Market Share by Type (2018-2029)
7.3 Europe Nanotechnology Drug Delivery Systems Market Size by Application
7.3.1 Europe Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023)
7.3.2 Europe Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029)
7.3.3 Europe Nanotechnology Drug Delivery Systems Market Share by Application (2018-2029)
7.4 Europe Nanotechnology Drug Delivery Systems Market Size by Country
7.4.1 Europe Nanotechnology Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2018-2023)
7.4.3 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nanotechnology Drug Delivery Systems Market Size (2018-2029)
8.2 China Nanotechnology Drug Delivery Systems Market Size by Type
8.2.1 China Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023)
8.2.2 China Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029)
8.2.3 China Nanotechnology Drug Delivery Systems Market Share by Type (2018-2029)
8.3 China Nanotechnology Drug Delivery Systems Market Size by Application
8.3.1 China Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023)
8.3.2 China Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029)
8.3.3 China Nanotechnology Drug Delivery Systems Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Nanotechnology Drug Delivery Systems Market Size (2018-2029)
9.2 Asia Nanotechnology Drug Delivery Systems Market Size by Type
9.2.1 Asia Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023)
9.2.2 Asia Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029)
9.2.3 Asia Nanotechnology Drug Delivery Systems Market Share by Type (2018-2029)
9.3 Asia Nanotechnology Drug Delivery Systems Market Size by Application
9.3.1 Asia Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023)
9.3.2 Asia Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029)
9.3.3 Asia Nanotechnology Drug Delivery Systems Market Share by Application (2018-2029)
9.4 Asia Nanotechnology Drug Delivery Systems Market Size by Region
9.4.1 Asia Nanotechnology Drug Delivery Systems Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Nanotechnology Drug Delivery Systems Market Size by Region (2018-2023)
9.4.3 Asia Nanotechnology Drug Delivery Systems Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AbbVie, Inc.
11.1.1 AbbVie, Inc. Company Details
11.1.2 AbbVie, Inc. Business Overview
11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Introduction
11.1.4 AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.1.5 AbbVie, Inc. Recent Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Nanotechnology Drug Delivery Systems Introduction
11.2.4 Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.2.5 Amgen Inc. Recent Developments
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Nanotechnology Drug Delivery Systems Introduction
11.3.4 Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.3.5 Celgene Corporation Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Introduction
11.4.4 Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Introduction
11.5.4 Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.5.5 Merck & Co., Inc. Recent Developments
11.6 Novartis International AG
11.6.1 Novartis International AG Company Details
11.6.2 Novartis International AG Business Overview
11.6.3 Novartis International AG Nanotechnology Drug Delivery Systems Introduction
11.6.4 Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.6.5 Novartis International AG Recent Developments
11.7 Perrigo Company plc
11.7.1 Perrigo Company plc Company Details
11.7.2 Perrigo Company plc Business Overview
11.7.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Introduction
11.7.4 Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.7.5 Perrigo Company plc Recent Developments
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Details
11.8.2 Pfizer, Inc. Business Overview
11.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Introduction
11.8.4 Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.8.5 Pfizer, Inc. Recent Developments
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Details
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.10 3M
11.10.1 3M Company Details
11.10.2 3M Business Overview
11.10.3 3M Nanotechnology Drug Delivery Systems Introduction
11.10.4 3M Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.10.5 3M Recent Developments
11.11 Zosano Pharma
11.11.1 Zosano Pharma Company Details
11.11.2 Zosano Pharma Business Overview
11.11.3 Zosano Pharma Nanotechnology Drug Delivery Systems Introduction
11.11.4 Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.11.5 Zosano Pharma Recent Developments
11.12 Becton-Dickinson?BD?Technologies
11.12.1 Becton-Dickinson?BD?Technologies Company Details
11.12.2 Becton-Dickinson?BD?Technologies Business Overview
11.12.3 Becton-Dickinson?BD?Technologies Nanotechnology Drug Delivery Systems Introduction
11.12.4 Becton-Dickinson?BD?Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.12.5 Becton-Dickinson?BD?Technologies Recent Developments
11.13 Nanopass Technologies
11.13.1 Nanopass Technologies Company Details
11.13.2 Nanopass Technologies Business Overview
11.13.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Introduction
11.13.4 Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.13.5 Nanopass Technologies Recent Developments
11.14 Corium
11.14.1 Corium Company Details
11.14.2 Corium Business Overview
11.14.3 Corium Nanotechnology Drug Delivery Systems Introduction
11.14.4 Corium Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.14.5 Corium Recent Developments
11.15 Valeritas
11.15.1 Valeritas Company Details
11.15.2 Valeritas Business Overview
11.15.3 Valeritas Nanotechnology Drug Delivery Systems Introduction
11.15.4 Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.15.5 Valeritas Recent Developments
11.16 Nitto
11.16.1 Nitto Company Details
11.16.2 Nitto Business Overview
11.16.3 Nitto Nanotechnology Drug Delivery Systems Introduction
11.16.4 Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.16.5 Nitto Recent Developments
11.17 Microdermics
11.17.1 Microdermics Company Details
11.17.2 Microdermics Business Overview
11.17.3 Microdermics Nanotechnology Drug Delivery Systems Introduction
11.17.4 Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.17.5 Microdermics Recent Developments
11.18 TheraJect
11.18.1 TheraJect Company Details
11.18.2 TheraJect Business Overview
11.18.3 TheraJect Nanotechnology Drug Delivery Systems Introduction
11.18.4 TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.18.5 TheraJect Recent Developments
11.19 Vaxxas
11.19.1 Vaxxas Company Details
11.19.2 Vaxxas Business Overview
11.19.3 Vaxxas Nanotechnology Drug Delivery Systems Introduction
11.19.4 Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.19.5 Vaxxas Recent Developments
11.20 Lohmann Therapie-Systeme AG
11.20.1 Lohmann Therapie-Systeme AG Company Details
11.20.2 Lohmann Therapie-Systeme AG Business Overview
11.20.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Introduction
11.20.4 Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023)
11.20.5 Lohmann Therapie-Systeme AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Nanocrystals
Table 3. Key Players of Nanoparticles
Table 4. Key Players of Dendrimers
Table 5. Key Players of Gold Nanoparticles
Table 6. Key Players of Fullerenes
Table 7. Key Players of Liposomes
Table 8. Key Players of Nanotubes
Table 9. Key Players of Others
Table 10. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 11. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 12. Global Nanotechnology Drug Delivery Systems Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Nanotechnology Drug Delivery Systems Market Share by Region (2018-2023)
Table 14. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 15. Global Nanotechnology Drug Delivery Systems Market Share by Region (2024-2029)
Table 16. Nanotechnology Drug Delivery Systems Market Trends
Table 17. Nanotechnology Drug Delivery Systems Market Drivers
Table 18. Nanotechnology Drug Delivery Systems Market Challenges
Table 19. Nanotechnology Drug Delivery Systems Market Restraints
Table 20. Global Nanotechnology Drug Delivery Systems Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Nanotechnology Drug Delivery Systems Revenue Share by Players (2018-2023)
Table 22. Global Top Nanotechnology Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery Systems as of 2022)
Table 23. Global Nanotechnology Drug Delivery Systems Industry Ranking 2021 VS 2022 VS 2023
Table 24. Global 5 Largest Players Market Share by Nanotechnology Drug Delivery Systems Revenue (CR5 and HHI) & (2018-2023)
Table 25. Global Key Players of Nanotechnology Drug Delivery Systems, Headquarters and Area Served
Table 26. Global Key Players of Nanotechnology Drug Delivery Systems, Product and Application
Table 27. Global Key Players of Nanotechnology Drug Delivery Systems, Product and Application
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2018-2023)
Table 31. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 32. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2024-2029)
Table 33. Global Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Nanotechnology Drug Delivery Systems Revenue Share by Application (2018-2023)
Table 35. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 36. Global Nanotechnology Drug Delivery Systems Revenue Share by Application (2024-2029)
Table 37. North America Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 38. North America Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029) & (US$ Million)
Table 39. North America Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 40. North America Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029) & (US$ Million)
Table 41. North America Nanotechnology Drug Delivery Systems Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. North America Nanotechnology Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 43. North America Nanotechnology Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 44. Europe Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 45. Europe Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029) & (US$ Million)
Table 46. Europe Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 47. Europe Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029) & (US$ Million)
Table 48. Europe Nanotechnology Drug Delivery Systems Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 50. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 51. China Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 52. China Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029) & (US$ Million)
Table 53. China Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 54. China Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 56. Asia Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029) & (US$ Million)
Table 57. Asia Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 58. Asia Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029) & (US$ Million)
Table 59. Asia Nanotechnology Drug Delivery Systems Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 60. Asia Nanotechnology Drug Delivery Systems Market Size by Region (2018-2023) & (US$ Million)
Table 61. Asia Nanotechnology Drug Delivery Systems Market Size by Region (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Type (2024-2029) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Application (2024-2029) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 67. Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 68. Middle East, Africa, and Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 69. AbbVie, Inc. Company Details
Table 70. AbbVie, Inc. Business Overview
Table 71. AbbVie, Inc. Nanotechnology Drug Delivery Systems Product
Table 72. AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 73. AbbVie, Inc. Recent Developments
Table 74. Amgen Inc. Company Details
Table 75. Amgen Inc. Business Overview
Table 76. Amgen Inc. Nanotechnology Drug Delivery Systems Product
Table 77. Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 78. Amgen Inc. Recent Developments
Table 79. Celgene Corporation Company Details
Table 80. Celgene Corporation Business Overview
Table 81. Celgene Corporation Nanotechnology Drug Delivery Systems Product
Table 82. Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 83. Celgene Corporation Recent Developments
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Nanotechnology Drug Delivery Systems Product
Table 87. Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 88. Johnson & Johnson Recent Developments
Table 89. Merck & Co., Inc. Company Details
Table 90. Merck & Co., Inc. Business Overview
Table 91. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product
Table 92. Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 93. Merck & Co., Inc. Recent Developments
Table 94. Novartis International AG Company Details
Table 95. Novartis International AG Business Overview
Table 96. Novartis International AG Nanotechnology Drug Delivery Systems Product
Table 97. Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 98. Novartis International AG Recent Developments
Table 99. Perrigo Company plc Company Details
Table 100. Perrigo Company plc Business Overview
Table 101. Perrigo Company plc Nanotechnology Drug Delivery Systems Product
Table 102. Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 103. Perrigo Company plc Recent Developments
Table 104. Pfizer, Inc. Company Details
Table 105. Pfizer, Inc. Business Overview
Table 106. Pfizer, Inc. Nanotechnology Drug Delivery Systems Product
Table 107. Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 108. Pfizer, Inc. Recent Developments
Table 109. Teva Pharmaceutical Industries Ltd. Company Details
Table 110. Teva Pharmaceutical Industries Ltd. Business Overview
Table 111. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product
Table 112. Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 113. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 114. 3M Company Details
Table 115. 3M Business Overview
Table 116. 3M Nanotechnology Drug Delivery Systems Product
Table 117. 3M Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 118. 3M Recent Developments
Table 119. Zosano Pharma Company Details
Table 120. Zosano Pharma Business Overview
Table 121. Zosano Pharma Nanotechnology Drug Delivery Systems Product
Table 122. Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 123. Zosano Pharma Recent Developments
Table 124. Becton-Dickinson?BD?Technologies Company Details
Table 125. Becton-Dickinson?BD?Technologies Business Overview
Table 126. Becton-Dickinson?BD?Technologies Nanotechnology Drug Delivery Systems Product
Table 127. Becton-Dickinson?BD?Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 128. Becton-Dickinson?BD?Technologies Recent Developments
Table 129. Nanopass Technologies Company Details
Table 130. Nanopass Technologies Business Overview
Table 131. Nanopass Technologies Nanotechnology Drug Delivery Systems Product
Table 132. Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 133. Nanopass Technologies Recent Developments
Table 134. Corium Company Details
Table 135. Corium Business Overview
Table 136. Corium Nanotechnology Drug Delivery Systems Product
Table 137. Corium Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 138. Corium Recent Developments
Table 139. Valeritas Company Details
Table 140. Valeritas Business Overview
Table 141. Valeritas Nanotechnology Drug Delivery Systems Product
Table 142. Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 143. Valeritas Recent Developments
Table 144. Nitto Company Details
Table 145. Nitto Business Overview
Table 146. Nitto Nanotechnology Drug Delivery Systems Product
Table 147. Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 148. Nitto Recent Developments
Table 149. Microdermics Company Details
Table 150. Microdermics Business Overview
Table 151. Microdermics Nanotechnology Drug Delivery Systems Product
Table 152. Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 153. Microdermics Recent Developments
Table 154. TheraJect Company Details
Table 155. TheraJect Business Overview
Table 156. TheraJect Nanotechnology Drug Delivery Systems Product
Table 157. TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 158. TheraJect Recent Developments
Table 159. Vaxxas Company Details
Table 160. Vaxxas Business Overview
Table 161. Vaxxas Nanotechnology Drug Delivery Systems Product
Table 162. Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 163. Vaxxas Recent Developments
Table 164. Lohmann Therapie-Systeme AG Company Details
Table 165. Lohmann Therapie-Systeme AG Business Overview
Table 166. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product
Table 167. Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 168. Lohmann Therapie-Systeme AG Recent Developments
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Nanotechnology Drug Delivery Systems Market Share by Type: 2022 VS 2029
Figure 3. Nanocrystals Features
Figure 4. Nanoparticles Features
Figure 5. Dendrimers Features
Figure 6. Gold Nanoparticles Features
Figure 7. Fullerenes Features
Figure 8. Liposomes Features
Figure 9. Nanotubes Features
Figure 10. Others Features
Figure 11. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global Nanotechnology Drug Delivery Systems Market Share by Application: 2022 VS 2029
Figure 13. Immunology Case Studies
Figure 14. Cardiovascular Case Studies
Figure 15. Neurology Case Studies
Figure 16. Oncology Case Studies
Figure 17. Others Case Studies
Figure 18. Nanotechnology Drug Delivery Systems Report Years Considered
Figure 19. Global Nanotechnology Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Nanotechnology Drug Delivery Systems Market Size, (US$ Million), 2018 VS 2022 VS 2029
Fi